[Continuous ambulatory intravenous morphine infusion for pain therapy in advanced ovarian cancer].
We report on a female outpatient with cancer of the ovary, who received continuous intravenous morphine infusion for terminal pain control. The patient was treated over a period of 48 days with a morphine dosage ranging from 10 to 60 mg/h, which kept her free of pain. With treatment, she was alert, communicative with her relatives and moved freely. At a later stage, we complemented the treatment with Diazepam and Haloperidol. No side-effects were observed over the whole period of morphine infusion.
Sorge
J
J
Abteilung IV, Zentrum Anästhesiologie, Medizinischen Hochschule Hannover.
Schönborn
I
I
Günter
H H
HH
Steffmann
B
B
Hilfrich
J
J
Kühnle
H
H
D003975:Diazepam / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage; D006801:Humans; D007260:Infusion Pumps; D008875:Middle Aged; D009020:Morphine / Q000008:administration & dosage*; D010051:Ovarian Neoplasms / Q000503:physiopathology*; D010148:Intractable Pain / Q000188:drug therapy*; D010166:Palliative Care / Q000379:methods*
D009020:Morphine; D006220:Haloperidol; D003975:Diazepam